Neoplasms by Site Completed Phase 1 Trials for Abexinostat (DB12565)

IndicationStatusPhase
DBCOND0030096 (Neoplasms by Site)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00562224Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer PatientsTreatment